Literature DB >> 27153925

Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency.

Stéphane Bally1, Hanna Debiec2,3, Denise Ponard4, Frédérique Dijoud5, John Rendu6, Julien Fauré6, Pierre Ronco7,3,8, Chantal Dumestre-Perard4.   

Abstract

Most patients with idiopathic membranous nephropathy (IMN) have IgG4 autoantibodies against phospholipase A2 receptor (PLA2R). C3 and C5b-9 are found in immune deposits of IMN kidney biopsy specimens, but the pathway of complement activation in IMN remains elusive. We report the case of a patient who developed IMN with intense staining for PLA2R, IgG4, C3, C5b-9, factor B, and properdin and very weak staining for C1q, C4d, and IgG1. Measurement of mannan binding lectin (MBL) antigenic level and activity revealed MBL deficiency. Genotyping revealed a heterozygous (A/C) polymorphism in codon 57 of MBL2 exon 1 associated with homozygous and heterozygous variations in the promoter region at -550 (L/L) and -221 (X/Y), respectively, suggesting that the patient harbored the LXA/LYC haplotypes linked to MBL deficiency. Genetic sequencing in 77 consecutive patients with IMN identified four patients with MBL2 promoter and coding region variations associated with MBL deficiency and the same complement pattern in immune deposits as the index patient. In contrast, patients with wild-type MBL2 had immune deposits with intense Cd4 staining. Thus, IMN can develop in patients with complete MBL deficiency, with complement activated mainly by the alternative pathway, whereas the lectin pathway is also activated in those with wild-type MBL2.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  complement; glomerular disease; immunohistochemistry; membranous nephropathy

Mesh:

Substances:

Year:  2016        PMID: 27153925      PMCID: PMC5118485          DOI: 10.1681/ASN.2015101155

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.

Authors:  Nicola M Tomas; Laurence H Beck; Catherine Meyer-Schwesinger; Barbara Seitz-Polski; Hong Ma; Gunther Zahner; Guillaume Dolla; Elion Hoxha; Udo Helmchen; Anne-Sophie Dabert-Gay; Delphine Debayle; Michael Merchant; Jon Klein; David J Salant; Rolf A K Stahl; Gérard Lambeau
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

2.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Authors:  A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

Review 3.  Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Lancet       Date:  2015-05-16       Impact factor: 79.321

4.  IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression.

Authors:  Cheng Cheng Huang; Amy Lehman; Alia Albawardi; Anjali Satoskar; Sergey Brodsky; Gyongyi Nadasdy; Lee Hebert; Brad Rovin; Tibor Nadasdy
Journal:  Mod Pathol       Date:  2013-01-18       Impact factor: 7.842

Review 5.  Mannose-binding lectin deficiency--revisited.

Authors:  Peter Garred; Flemming Larsen; Hans O Madsen; Claus Koch
Journal:  Mol Immunol       Date:  2003-09       Impact factor: 4.407

6.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

7.  Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.

Authors:  Li Zhu; Ya-Ling Zhai; Feng-Mei Wang; Ping Hou; Ji-Cheng Lv; Da-Min Xu; Su-Fang Shi; Li-Jun Liu; Feng Yu; Ming-Hui Zhao; Jan Novak; Ali G Gharavi; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2014-09-09       Impact factor: 10.121

Review 8.  Humoral pattern recognition molecules: mannan-binding lectin and ficolins.

Authors:  Steffen Thiel; Mihaela Gadjeva
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

9.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency.

Authors:  P Garred; H O Madsen; B Hofmann; A Svejgaard
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

Review 10.  Mannose-binding lectin in innate immunity: past, present and future.

Authors:  R M Dommett; N Klein; M W Turner
Journal:  Tissue Antigens       Date:  2006-09
View more
  35 in total

1.  Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.

Authors:  George Haddad; Johan M Lorenzen; Hong Ma; Noortje de Haan; Harald Seeger; Christelle Zaghrini; Simone Brandt; Malte Kölling; Urs Wegmann; Bence Kiss; Gábor Pál; Péter Gál; Rudolf P Wüthrich; Manfred Wuhrer; Laurence H Beck; David J Salant; Gérard Lambeau; Andreas D Kistler
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 2.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

4.  Identification of molecular mechanism and key biomarkers in membranous nephropathy by bioinformatics analysis.

Authors:  Zhaocheng Dong; Yunling Geng; Pingna Zhang; Jingyi Tang; Zijing Cao; Huijuan Zheng; Jing Guo; Chao Zhang; Baoli Liu; Wei Jing Liu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy.

Authors:  Yan-Ni Wang; Hao-Yu Feng; Xin Nie; Ya-Mei Zhang; Liang Zou; Xia Li; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 6.  Unmet challenges in membranous nephropathy.

Authors:  David J Salant
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

Review 7.  PLA2R and THSD7A: Disparate Paths to the Same Disease?

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

8.  Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.

Authors:  Ren Wang; Meiqiu Wang; Zhengkun Xia; Chunlin Gao; Zhuo Shi; Xiang Fang; Heyan Wu; Yingchao Peng
Journal:  J Nephrol       Date:  2020-08-08       Impact factor: 3.902

Review 9.  A clinical approach to children with C3 glomerulopathy.

Authors:  Marina Vivarelli; Nicole van de Kar; Raffaella Labbadia; Francesca Diomedi-Camassei; Joshua M Thurman
Journal:  Pediatr Nephrol       Date:  2021-05-18       Impact factor: 3.714

Review 10.  Advances in Pathogenesis of Idiopathic Membranous Nephropathy.

Authors:  Zhifeng Xu; Lu Chen; Huiling Xiang; Chun Zhang; Jing Xiong
Journal:  Kidney Dis (Basel)       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.